{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:50:08Z","timestamp":1784029808315,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012779","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000}}],"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012640","name":"ExxonMobil Foundation","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/501100012640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI124678"],"award-info":[{"award-number":["AI124678"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI050234"],"award-info":[{"award-number":["AI050234"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI147628"],"award-info":[{"award-number":["AI147628"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Human Frontiers Science Program Long-Term Fellowship","award":["LT000976\/2016-L"],"award-info":[{"award-number":["LT000976\/2016-L"]}]},{"name":"National Institute of Health","award":["R21 AI174085"],"award-info":[{"award-number":["R21 AI174085"]}]},{"name":"Eberly College of Science and the Huck Institutes of the Life Sciences at The Pennsylvania State University"},{"name":"Penn State Eberly Research Fellowship"},{"name":"Huck Institutes' Metabolomics Core Facility"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    Malaria remains a pressing global health challenge, with rising drug resistance threatening current treatment strategies. Partial resistance to dihydroartemisinin-piperaquine (DHA-PPQ) has emerged in Southeast Asia, particularly in\n                    <jats:italic>\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    <\/jats:italic>\n                    strains from Cambodia. While artemisinin partial resistance is associated with mutations in\n                    <jats:italic>\n                      <jats:italic>kelch13<\/jats:italic>\n                    <\/jats:italic>\n                    , reduced PPQ sensitivity has been linked to increased copy numbers of the aspartic protease genes\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>III<\/jats:italic>\n                    and mutations in the chloroquine resistance transporter. In this study, we demonstrate the effective use of CRISPR-Cas9 technology to generate single knockouts (KO) of\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>\n                      <jats:italic>plasmepsin III<\/jats:italic>\n                    <\/jats:italic>\n                    , as well as a double KO of both genes, in two isogenic Cambodian parasites with varying numbers of\n                    <jats:italic>\n                      <jats:italic>plasmepsin<\/jats:italic>\n                    <\/jats:italic>\n                    gene copies. The deletion of\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    and\/or\n                    <jats:italic>III<\/jats:italic>\n                    increased parasite sensitivity to PPQ. We explored several hypotheses to understand how an increased\n                    <jats:italic>\n                      <jats:italic>plasmepsin<\/jats:italic>\n                    <\/jats:italic>\n                    gene copy number might influence parasite survival under high PPQ pressure. Our findings indicate that protease inhibitors have a minimal impact on parasite susceptibility to PPQ. Additionally, parasites with higher\n                    <jats:italic>\n                      <jats:italic>plasmepsin<\/jats:italic>\n                    <\/jats:italic>\n                    gene copy numbers did not exhibit significantly increased hemoglobin digestion, differences in peptide composition, nor did they produce different amounts of free heme following PPQ treatment compared to wildtype (single copy) parasites. Interestingly, hemoglobin digestion was slowed in parasites with\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    deletions. We also found that culturing parasites with different\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>III<\/jats:italic>\n                    copies in amino acid-limited media had little impact on parasite sensitivity to high-dose PPQ. By treating parasites with modulators of digestive vacuole (DV) homeostasis, we found that changes in DV pH potentially affect their response to PPQ. Our research highlights the crucial role of increased\n                    <jats:italic>\n                      <jats:italic>plasmepsin II and III<\/jats:italic>\n                    <\/jats:italic>\n                    gene copy numbers in modulating response to PPQ and begins to uncover the molecular and physiological mechanisms underlying the contribution of\n                    <jats:italic>\n                      <jats:italic>plasmepsin II<\/jats:italic>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>III<\/jats:italic>\n                    amplification to PPQ resistance in Cambodian parasites.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1012779","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:57:33Z","timestamp":1753725453000},"page":"e1012779","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["The plasmepsin-piperaquine paradox persists in Plasmodium falciparum"],"prefix":"10.1371","volume":"21","author":[{"given":"Breanna","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel W.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Hagenah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachel","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Llin\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyann F.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-9766","authenticated-orcid":true,"given":"Selina","family":"Bopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ppat.1012779.ref001","unstructured":"Organization WH. World malaria report 2023. 2023."},{"key":"ppat.1012779.ref002","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","author":"RW van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ppat.1012779.ref003","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.00686-12","article-title":"Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010","volume":"57","author":"R Leang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ppat.1012779.ref004","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/AAC.00835-15","article-title":"Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: Dihydroartemisinin-piperaquine open-label multicenter clinical assessment","volume":"59","author":"R Leang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1012779.ref005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"V Duru","year":"2015","journal-title":"BMC Med"},{"issue":"6","key":"ppat.1012779.ref006","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"MD Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ppat.1012779.ref007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12936-016-1569-y","article-title":"Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand","volume":"15","author":"S Chaorattanakawee","year":"2016","journal-title":"Malar J"},{"key":"ppat.1012779.ref008","unstructured":"Organization WH. World malaria report 2018. 2018."},{"issue":"5","key":"ppat.1012779.ref009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"EA Ashley","year":"2014","journal-title":"N Engl J Med"},{"issue":"7481","key":"ppat.1012779.ref010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature"},{"issue":"6220","key":"ppat.1012779.ref011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"J Straimer","year":"2015","journal-title":"Science"},{"key":"ppat.1012779.ref012","doi-asserted-by":"crossref","unstructured":"Anderson TJ, Nair S, McDew-White M, Cheeseman IH, Nkhoma S, Bilgic F, et al. Population parameters underlying an ongoing soft sweep in Southeast Asian malaria parasites. Mol Biol Evol. 2017;34(1):131\u201344. https:\/\/doi.org\/10.1093\/molbev\/msw228\u00a028025270","DOI":"10.1093\/molbev\/msw228"},{"issue":"5","key":"ppat.1012779.ref013","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"S Takala-Harrison","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1012779.ref014","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01134-19","article-title":"Role of Plasmodium falciparum kelch 13 protein mutations in P. falciparum populations from northeastern Myanmar in mediating artemisinin resistance","volume":"11","author":"FA Siddiqui","year":"2020","journal-title":"mBio"},{"issue":"2","key":"ppat.1012779.ref015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"B Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ppat.1012779.ref016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"R Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ppat.1012779.ref017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02309-17","article-title":"Inactivation of Plasmepsins 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine","volume":"62","author":"A Mukherjee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1012779.ref018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpddr.2018.11.004","article-title":"Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine","volume":"9","author":"D Loesbanluechai","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"4","key":"ppat.1012779.ref019","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/infdis\/jix334","article-title":"Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity","volume":"216","author":"S Agrawal","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1012779.ref020","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"LS Ross","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"ppat.1012779.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00303-17","article-title":"A variant PfCRT isoform can contribute to Plasmodium falciparum resistance to the first-line partner drug piperaquine","volume":"8","author":"SK Dhingra","year":"2017","journal-title":"MBio"},{"issue":"10","key":"ppat.1012779.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010926","article-title":"Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages","volume":"18","author":"J Okombo","year":"2022","journal-title":"PLoS Pathog"},{"issue":"11","key":"ppat.1012779.ref023","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/infdis\/jiac365","article-title":"Mutant PfCRT can mediate piperaquine resistance in African Plasmodium falciparum with reduced fitness and increased susceptibility to other antimalarials","volume":"226","author":"KJ Wicht","year":"2022","journal-title":"J Infect Dis"},{"issue":"2","key":"ppat.1012779.ref024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(23)00502-9","article-title":"Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study","volume":"24","author":"C Florimond","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ppat.1012779.ref025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"WL Hamilton","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ppat.1012779.ref026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"C Amaratunga","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ppat.1012779.ref027","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study","volume":"20","author":"M Imwong","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ppat.1012779.ref028","article-title":"Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance","volume":"18","author":"JL Small-Saunders","year":"2022","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1012779.ref029","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"S Bopp","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"ppat.1012779.ref030","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"R Banerjee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ppat.1012779.ref031","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1172\/JCI117140","article-title":"Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway","volume":"93","author":"IY Gluzman","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"ppat.1012779.ref032","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.173.4.961","article-title":"Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease","volume":"173","author":"DE Goldberg","year":"1991","journal-title":"J Exp Med"},{"issue":"23","key":"ppat.1012779.ref033","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.272.23.14961","article-title":"Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II","volume":"272","author":"SE Francis","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"ppat.1012779.ref034","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1074\/jbc.M409740200","article-title":"The role of Plasmodium falciparum food vacuole plasmepsins","volume":"280","author":"J Liu","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"ppat.1012779.ref035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12936-020-03436-w","article-title":"A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples","volume":"19","author":"M Kucharski","year":"2020","journal-title":"Malar J"},{"issue":"12","key":"ppat.1012779.ref036","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/AAC.00882-09","article-title":"Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors","volume":"53","author":"PA Moura","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"23","key":"ppat.1012779.ref037","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.0601876103","article-title":"Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems","volume":"103","author":"J Liu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1012779.ref038","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jinorgbio.2007.12.004","article-title":"Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation","volume":"102","author":"TJ Egan","year":"2008","journal-title":"J Inorg Biochem"},{"issue":"16","key":"ppat.1012779.ref039","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.1501023112","article-title":"Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine","volume":"112","author":"KN Olafson","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ppat.1012779.ref040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12936-020-03249-x","article-title":"Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2\/3 copy number variation in Plasmodium falciparum","volume":"19","author":"MR Ansbro","year":"2020","journal-title":"Malar J"},{"issue":"37","key":"ppat.1012779.ref041","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum","volume":"275","author":"BR Shenai","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"ppat.1012779.ref042","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1462-5822.2008.01242.x","article-title":"Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytes","volume":"11","author":"S Glushakova","year":"2009","journal-title":"Cell Microbiol"},{"issue":"19","key":"ppat.1012779.ref043","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1073\/pnas.93.19.10034","article-title":"Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum","volume":"93","author":"AM Silva","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1012779.ref044","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12936-015-0729-9","article-title":"Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials","volume":"14","author":"JM Combrinck","year":"2015","journal-title":"Malar J"},{"issue":"1","key":"ppat.1012779.ref045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"JM Combrinck","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"11","key":"ppat.1012779.ref046","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1128\/AAC.01224-16","article-title":"Metabolomic profiling of the malaria box reveals antimalarial target pathways","volume":"60","author":"EL Allman","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ppat.1012779.ref047","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0006-2952(90)90302-2","article-title":"Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug","volume":"40","author":"TG Geary","year":"1990","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"ppat.1012779.ref048","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1073\/pnas.82.9.2784","article-title":"Susceptibility of human malaria parasites to chloroquine is pH dependent","volume":"82","author":"A Yayon","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1012779.ref049","doi-asserted-by":"crossref","DOI":"10.1016\/0006-2952(91)90407-V","article-title":"Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains","volume":"42","author":"V Ferrari","year":"1991","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"ppat.1012779.ref050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2958.2006.05368.x","article-title":"PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX","volume":"62","author":"PG Bray","year":"2006","journal-title":"Mol Microbiol"},{"issue":"8","key":"ppat.1012779.ref051","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1073\/pnas.87.8.2931","article-title":"Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle","volume":"87","author":"DE Goldberg","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1012779.ref052","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1242\/jcs.02795","article-title":"The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance","volume":"119","author":"R Hayward","year":"2006","journal-title":"J Cell Sci"},{"issue":"3","key":"ppat.1012779.ref053","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20070934","article-title":"Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum","volume":"407","author":"N Klonis","year":"2007","journal-title":"Biochem J"},{"issue":"4","key":"ppat.1012779.ref054","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1462-5822.2006.00847.x","article-title":"Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin","volume":"9","author":"Y Kuhn","year":"2007","journal-title":"Cell Microbiol"},{"key":"ppat.1012779.ref055","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1242\/jcs.016758","article-title":"A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites","volume":"121","author":"AM Lehane","year":"2008","journal-title":"J Cell Sci"},{"issue":"21","key":"ppat.1012779.ref056","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/0006-2952(86)90668-4","article-title":"Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum","volume":"35","author":"TG Geary","year":"1986","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"ppat.1012779.ref057","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/0006-2952(89)90550-9","article-title":"Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity","volume":"38","author":"H Ginsburg","year":"1989","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"ppat.1012779.ref058","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1074\/jbc.M208648200","article-title":"Acidification of the malaria parasite\u2019s digestive vacuole by a H+-ATPase and a H+-pyrophosphatase","volume":"278","author":"KJ Saliba","year":"2003","journal-title":"J Biol Chem"},{"issue":"52","key":"ppat.1012779.ref059","doi-asserted-by":"crossref","first-page":"54088","DOI":"10.1074\/jbc.M409605200","article-title":"Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy","volume":"279","author":"AL Omara-Opyene","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"ppat.1012779.ref060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2958.2007.05768.x","article-title":"Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function","volume":"65","author":"JA Bonilla","year":"2007","journal-title":"Mol Microbiol"},{"issue":"1","key":"ppat.1012779.ref061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(03)00137-3","article-title":"Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man","volume":"130","author":"JB Dame","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"ppat.1012779.ref062","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.145.2.363","article-title":"Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum","volume":"145","author":"PG Bray","year":"1999","journal-title":"J Cell Biol"},{"issue":"8","key":"ppat.1012779.ref063","article-title":"Influence of LAR and VAR on para-aminopyridine antimalarials targetting haematin in chloroquine-resistance","volume":"11","author":"DC Warhurst","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"ppat.1012779.ref064","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bcp.2007.03.011","article-title":"Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases","volume":"73","author":"DC Warhurst","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"ppat.1012779.ref065","doi-asserted-by":"crossref","DOI":"10.1021\/cg4009416","article-title":"Synthetic Hemozoin (\u03b2-Hematin) Crystals Nucleate at the Surface of Neutral Lipid Droplets that Control Their Sizes","volume":"13","author":"MA Ambele","year":"2013","journal-title":"Cryst Growth Des"},{"issue":"47","key":"ppat.1012779.ref066","doi-asserted-by":"crossref","first-page":"10107","DOI":"10.1021\/bi101397u","article-title":"The neutral lipid composition present in the digestive vacuole of Plasmodium falciparum concentrates heme and mediates \u03b2-hematin formation with an unusually low activation energy","volume":"49","author":"AN Hoang","year":"2010","journal-title":"Biochemistry"},{"issue":"6473","key":"ppat.1012779.ref067","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"J Birnbaum","year":"2020","journal-title":"Science"},{"issue":"12","key":"ppat.1012779.ref068","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.chom.2021.11.002","article-title":"The parasitophorous vacuole nutrient channel is critical for drug access in malaria parasites and modulates the artemisinin resistance fitness cost","volume":"29","author":"P Mes\u00e9n-Ram\u00edrez","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"7","key":"ppat.1012779.ref069","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00805-24","article-title":"A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II\/III to piperaquine drug resistance","volume":"15","author":"J Kane","year":"2024","journal-title":"mBio"},{"issue":"3","key":"ppat.1012779.ref070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","article-title":"Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study","volume":"18","author":"R Amato","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ppat.1012779.ref071","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-020-17781-6","article-title":"The natural function of the malaria parasite\u2019s chloroquine resistance transporter","volume":"11","author":"SH Shafik","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1012779.ref072","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1038\/s41598-018-31715-9","article-title":"Evidence for regulation of hemoglobin metabolism and intracellular ionic flux by the Plasmodium falciparum chloroquine resistance transporter","volume":"8","author":"AH Lee","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"ppat.1012779.ref073","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01101-22","article-title":"The knock-down of the chloroquine resistance transporter PfCRT ss linked to oligopeptide handling in Plasmodium falciparum","volume":"10","author":"CP Sanchez","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"5948","key":"ppat.1012779.ref074","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter","volume":"325","author":"RE Martin","year":"2009","journal-title":"Science"},{"issue":"52","key":"ppat.1012779.ref075","doi-asserted-by":"crossref","first-page":"36336","DOI":"10.1074\/jbc.M114.614206","article-title":"Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites","volume":"289","author":"S Bellanca","year":"2014","journal-title":"J Biol Chem"},{"issue":"7786","key":"ppat.1012779.ref076","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"J Kim","year":"2019","journal-title":"Nature"},{"issue":"6","key":"ppat.1012779.ref077","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011436","article-title":"PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport","volume":"19","author":"GM Gomez","year":"2023","journal-title":"PLoS Pathog"},{"key":"ppat.1012779.ref078","doi-asserted-by":"crossref","first-page":"915656","DOI":"10.3389\/fcimb.2022.915656","article-title":"Evaluation of the effect of gene duplication by genome editing on drug resistance in Plasmodium falciparum","volume":"12","author":"R Kubota","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"ppat.1012779.ref079","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1473-3099(19)30543-2","article-title":"Plasmodium falciparum resistance to piperaquine driven by PfCRT","volume":"19","author":"SK Dhingra","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"45","key":"ppat.1012779.ref080","article-title":"Mapping the genomic landscape of multidrug resistance in","volume":"9","author":"S Mok","year":"2023","journal-title":"Sci Adv"},{"issue":"1","key":"ppat.1012779.ref081","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01832-23","article-title":"Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology","volume":"15","author":"LM Hagenah","year":"2024","journal-title":"mBio"},{"key":"ppat.1012779.ref082","article-title":"Plasmodium falciparum African PfCRT mutant isoforms conducive to piperaquine resistance are infrequent and impart a major fitness cost","author":"LM Hagenah","year":"2024","journal-title":"J Infect Dis"},{"issue":"6","key":"ppat.1012779.ref083","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/jiab055","article-title":"Distribution and temporal dynamics of Plasmodium falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in Northern Cambodia","volume":"224","author":"B Shrestha","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"ppat.1012779.ref084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012013","article-title":"Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana","volume":"20","author":"M Vanhove","year":"2024","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1012779.ref085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12936-019-2756-4","article-title":"African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker","volume":"18","author":"D Leroy","year":"2019","journal-title":"Malar J"},{"issue":"14","key":"ppat.1012779.ref086","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1073\/pnas.1218412110","article-title":"Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum","volume":"110","author":"M Chugh","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"ppat.1012779.ref087","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system","volume":"32","author":"M Ghorbal","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ppat.1012779.ref088","article-title":"CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs","author":"CL Ng","year":"2016","journal-title":"Mol Microbiol"},{"issue":"20","key":"ppat.1012779.ref089","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.94.20.10931","article-title":"Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil","volume":"94","author":"DA Fidock","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9432","key":"ppat.1012779.ref090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"RN Price","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"ppat.1012779.ref091","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molbiopara.2007.05.005","article-title":"Genome wide gene amplifications and deletions in Plasmodium falciparum","volume":"155","author":"U Ribacke","year":"2007","journal-title":"Mol Biochem Parasitol"},{"issue":"6","key":"ppat.1012779.ref092","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","article-title":"Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening","volume":"51","author":"JD Johnson","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1012779.ref093","article-title":"Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools","volume":"44","author":"M Sud","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"47","key":"ppat.1012779.ref094","doi-asserted-by":"crossref","first-page":"33213","DOI":"10.1074\/jbc.274.47.33213","article-title":"pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a V-type H(+)-ATPase","volume":"274","author":"KJ Saliba","year":"1999","journal-title":"J Biol Chem"},{"issue":"1","key":"ppat.1012779.ref095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molbiopara.2008.07.001","article-title":"Acid extrusion from the intraerythrocytic malaria parasite is not via a Na(+)\/H(+) exchanger","volume":"162","author":"NJ Spillman","year":"2008","journal-title":"Mol Biochem Parasitol"},{"issue":"12","key":"ppat.1012779.ref096","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1074\/jbc.M311110200","article-title":"The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum","volume":"279","author":"RJ Allen","year":"2004","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012779","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:49:20Z","timestamp":1754329760000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012779"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Soldati-Favre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":96,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012779","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.28.625831","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}